» Articles » PMID: 39051843

Bufadienolide-Fatty Acid Conjugates from the Fertilized Eggs of Toad : Isolation, Characterization, Toxicity, and Antiproliferative Evaluation

Overview
Date 2024 Jul 25
PMID 39051843
Authors
Affiliations
Soon will be listed here.
Abstract

Bufadienolides (BDs) are a class of naturally occurring toxins present in amphibian toads. Serving as the chemical weapons, they exist not only in the adult toads but also in toad eggs. Guided by mass spectrometry (MS)-based component analysis and feature-based molecular networking (FBMN), 30 bufadienolide-fatty acid conjugates (BDFs) were isolated from the fertilized eggs of toad , including 25 previously undescribed compounds (-). Their chemical structures were elucidated by extensive spectroscopic analysis, chemical methods, and GC-MS. The toxicities of all BDFs and their corresponding free BDs were assessed using the zebrafish model. The structure-toxicity relationship analysis showed that the modification of BDs by hydroxy fatty acids can cause a significant increase of the toxicity. Furthermore, all the isolated compounds were evaluated for their antiproliferative activities in pancreatic cancer cell lines ASPC-1 and PANC10.05. The structure-activity relationship (SAR) analysis revealed that BDFs with hellebrigenin as the bufogenin moiety ( and ) exhibited the most potent antiproliferative effect. Further investigation into their functional mechanism demonstrated that and induced apoptosis in pancreatic cancer cells PANC10.05 and significantly suppressed the expression of the apoptosis-related gene c-MYC. In addition, and effectively inhibited the expression of the PI3K/Akt/mTOR pathway in PANC10.05. Moreover, we assessed the efficacy of and on cancer cells from various tissues and observed their broad-spectrum antiproliferative activity.

Citing Articles

Cinobufagin: Unveiling the hidden bufadienolide's promise in combating alimentary canal cancer development and progression - a comprehensive review.

Leme Boaro B, de Lima E, Maria D, Rici R, Cressoni Araujo A, Landgraf Guiguer E Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39976716 DOI: 10.1007/s00210-025-03902-9.